These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 20255934)

  • 1. Specific antigenic substances in the urine of typhus patients.
    FLECK L
    Tex Rep Biol Med; 1947; 5(2):168-72. PubMed ID: 20255934
    [No Abstract]   [Full Text] [Related]  

  • 2. Specific antigenic substances in the urine of typhus patients.
    FLECK L
    Med Dent Bull; 1947 Nov; 19(11):102-4. PubMed ID: 20270895
    [No Abstract]   [Full Text] [Related]  

  • 3. Studies on commercial typhus vaccines. II. The antigenic fractions of disrupted epidemic typhus rickettsiae.
    CHAMBERS LA; COHEN SS; CLAWSON JR
    J Immunol; 1950 Nov; 65(5):459-63. PubMed ID: 14794909
    [No Abstract]   [Full Text] [Related]  

  • 4. Diagnostic antigens for epidemic typhus, murine typhus and Rocky Mountain spotted fever.
    VAN DER SCHEER J; BOHNEL E; COX HR
    J Immunol; 1947 Aug; 56(4):365-75. PubMed ID: 20261082
    [No Abstract]   [Full Text] [Related]  

  • 5. [Excretion of rickettsia in the urine].
    OZBIL M
    Z Tropenmed Parasitol; 1955 Dec; 6(4):453-9. PubMed ID: 13300636
    [No Abstract]   [Full Text] [Related]  

  • 6. Studies on commercial typhus vaccines. I. The antigenic constituents of commercial epidemic typhus vaccine.
    CHAMBERS LA; CLAWSON JR
    J Immunol; 1950 Nov; 65(5):451-7. PubMed ID: 14794908
    [No Abstract]   [Full Text] [Related]  

  • 7. Studies on commercial typhus vaccines. III. The concentration and isolation of the Rickettsia-specific soluble antigen of commercial typhus vaccine.
    COHEN SS; CHAMBERS LA; CLAWSON JR
    J Immunol; 1950 Nov; 65(5):465-73. PubMed ID: 14794910
    [No Abstract]   [Full Text] [Related]  

  • 8. Studies on commercial typhus vaccines. IV. The chemical composition of the antigens of commercial typhus vaccine.
    COHEN SS
    J Immunol; 1950 Nov; 65(5):475-83. PubMed ID: 14794911
    [No Abstract]   [Full Text] [Related]  

  • 9. SEROLOGIC STUDIES OF PRIMARY EPIDEMIC TYPHUS AND RECRUDESCENT TYPHUS (BRILL-ZINSSER DISEASE). I. DIFFERENCES IN COMPLEMENT-FIXING ANTIBODIES: HIGH ANTIGEN REQUIREMENT AND HEAT LABILITY.
    MURRAY ES; GAON JA; O'CONNOR JM; MULAHASANOVIC M
    J Immunol; 1965 May; 94():723-33. PubMed ID: 14296293
    [No Abstract]   [Full Text] [Related]  

  • 10. The constitution of that rickettsia and soluble rickettsial antigen derived from the epidemic typhus vaccine.
    COHEN SS
    Fed Proc; 1946; 5(1 Pt 2):129. PubMed ID: 21066650
    [No Abstract]   [Full Text] [Related]  

  • 11. Employment of soluble antigen in screening tests for typhus complement fixation.
    BERGE TO
    Public Health Rep (1896); 1948 Apr; 63(17):529-37. PubMed ID: 18915383
    [No Abstract]   [Full Text] [Related]  

  • 12. The nature of the soluble antigen from typhus rickettsiae.
    SHEPARD CC; WYCKOFF RW
    Public Health Rep (1896); 1946 May; 61():761-7. PubMed ID: 20983030
    [No Abstract]   [Full Text] [Related]  

  • 13. Weil-Felix titres in normal subjects and non-typhus fever cases.
    SINGH M
    J Indian Med Assoc; 1956 Feb; 26(4):123-6. PubMed ID: 13306985
    [No Abstract]   [Full Text] [Related]  

  • 14. The specificity of antibody response in typhus fever. Its alteration during murine typhus infection as a result of previous exposure to epidemic typhus antigen.
    GOLDWASSER RA; SHEPARD CC; JORDAN ME; FOX JP
    J Immunol; 1959 Nov; 83():491-5. PubMed ID: 13848369
    [No Abstract]   [Full Text] [Related]  

  • 15. Studies on hemagglutination inhibition phenomena. I. The presence of inhibiting antigen in typhus-infected animals.
    DOWNS CM; FEVURLY J; MEYER MM
    J Immunol; 1955 Jul; 75(1):35-42. PubMed ID: 13242800
    [No Abstract]   [Full Text] [Related]  

  • 16. Studies of the serology of typhus fever; complement-fixing antibody response to vaccination and to infection.
    MALCOMSON ME; WISHART FO
    Can J Public Health; 1946 Oct; 37(10):411-21. PubMed ID: 21003059
    [No Abstract]   [Full Text] [Related]  

  • 17. [Louse-borne typhus potential and new technologies in prediction of epidemic louse-borne typhus outburst].
    Boev BV; Lobanov AV; Khudobin VV
    Vestn Ross Akad Med Nauk; 2008; (7):25-30. PubMed ID: 18756780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies of the serology of typhus fever; complement-fixing antigens of Rickettsia Prowazeki and their relationship to Proteus 0X19.
    WISHART PO; MALCOMSON ME
    Can J Public Health; 1946 Sep; 37():369-81. PubMed ID: 21003054
    [No Abstract]   [Full Text] [Related]  

  • 19. Antigenic relationships between the typhus and spotted fever groups of rickettsiae.
    Ormsbee R; Peacock M; Philip R; Casper E; Plorde J; Gabre-Kidan T; Wright L
    Am J Epidemiol; 1978 Jul; 108(1):53-9. PubMed ID: 99029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Complement fixation reactions with epidemic and endemic typhus antigens in the course of sporadic exanthematous typhus].
    WOJCIECHOWSKI E; LEWINSKA Z
    Med Dosw Mikrobiol; 1959; 11():125-34. PubMed ID: 13845587
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.